STRATA Skin Sciences, Inc. (SSKN)
NASDAQ: SSKN · IEX Real-Time Price · USD
3.340
+0.040 (1.21%)
Jul 26, 2024, 4:30 PM EDT - Market closed
STRATA Skin Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2013 |
|---|---|---|---|---|---|---|---|
| Revenue | 32.55 | 33.36 | 36.16 | 29.98 | 23.09 | 31.59 | Upgrade
|
| Revenue Growth (YoY) | -11.29% | -7.75% | 20.63% | 29.83% | -26.90% | 5.80% | Upgrade
|
| Cost of Revenue | 15.39 | 14.9 | 14.39 | 10.13 | 8.96 | 11.32 | Upgrade
|
| Gross Profit | 17.15 | 18.46 | 21.77 | 19.85 | 14.13 | 20.27 | Upgrade
|
| Selling, General & Admin | 22.53 | 23.46 | 25.39 | 22.82 | 16.94 | 22.28 | Upgrade
|
| Research & Development | 1.24 | 1.32 | 1.03 | 1.43 | 1.27 | 1 | Upgrade
|
| Operating Expenses | 23.78 | 24.78 | 26.42 | 24.25 | 18.21 | 23.28 | Upgrade
|
| Operating Income | -6.62 | -6.32 | -4.65 | -4.4 | -4.08 | -3.01 | Upgrade
|
| Interest Expense | -1.88 | -1.64 | -0.93 | -0.31 | -0.21 | -0.52 | Upgrade
|
| Interest & Investment Income | 0.24 | 0.23 | 0.09 | 0.02 | 0.15 | - | Upgrade
|
| EBT Excluding Unusual Items | -8.26 | -7.73 | -5.49 | -4.7 | -4.14 | -3.53 | Upgrade
|
| Impairment of Goodwill | -2.28 | -2.28 | - | - | - | - | Upgrade
|
| Other Unusual Items | -0.91 | -0.91 | - | 2.03 | - | -0.41 | Upgrade
|
| Pretax Income | -11.46 | -10.92 | -5.49 | -2.67 | -4.14 | -3.94 | Upgrade
|
| Income Tax Expense | -0.09 | -0.09 | 0.06 | 0.03 | 0.28 | -0.15 | Upgrade
|
| Net Income | -11.36 | -10.83 | -5.55 | -2.71 | -4.41 | -3.79 | Upgrade
|
| Net Income to Common | -11.36 | -10.83 | -5.55 | -2.71 | -4.41 | -3.79 | Upgrade
|
| Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 | 3 | Upgrade
|
| Shares Change (YoY) | 0.61% | 0.60% | 1.94% | 1.31% | 5.09% | 17.73% | Upgrade
|
| EPS (Basic) | -3.25 | -3.10 | -1.60 | -0.79 | -1.31 | -1.18 | Upgrade
|
| EPS (Diluted) | -3.25 | -3.10 | -1.60 | -0.79 | -1.31 | -1.18 | Upgrade
|
| Free Cash Flow | -4.46 | -5.54 | -4.66 | -2.15 | -0.06 | -0.56 | Upgrade
|
| Free Cash Flow Per Share | -1.27 | -1.59 | -1.34 | -0.63 | -0.02 | -0.18 | Upgrade
|
| Gross Margin | 52.71% | 55.34% | 60.20% | 66.22% | 61.21% | 64.17% | Upgrade
|
| Operating Margin | -20.35% | -18.95% | -12.86% | -14.68% | -17.65% | -9.53% | Upgrade
|
| Profit Margin | -34.91% | -32.47% | -15.35% | -9.03% | -19.11% | -12.00% | Upgrade
|
| Free Cash Flow Margin | -13.70% | -16.60% | -12.89% | -7.16% | -0.27% | -1.78% | Upgrade
|
| EBITDA | -1.22 | -0.77 | 0.64 | -0.67 | -0.49 | 1.49 | Upgrade
|
| EBITDA Margin | -3.74% | -2.30% | 1.78% | -2.22% | -2.13% | 4.73% | Upgrade
|
| D&A For EBITDA | 5.41 | 5.55 | 5.29 | 3.74 | 3.59 | 4.5 | Upgrade
|
| EBIT | -6.62 | -6.32 | -4.65 | -4.4 | -4.08 | -3.01 | Upgrade
|
| EBIT Margin | -20.35% | -18.95% | -12.86% | -14.68% | -17.65% | -9.53% | Upgrade
|
| Advertising Expenses | - | 0.5 | 1.6 | 1.6 | 0.7 | 1.94 | Upgrade
|
Source: S&P Capital IQ. Standard template.